查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2089001

動物疫苗市場：2026-2032年全球市場預測（依產品類型、動物種類、疾病、給藥途徑及通路分類）

Animal Vaccines Market by Product, Animal Type, Disease Type, Route of Administration, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物疫苗市場規模將成長至 234 億美元，複合年成長率為 6.99%。

主要市場統計數據
基準年 2025 145.8億美元
預計年份：2026年 155.3億美元
預測年份 2032 234億美元
複合年成長率 (%) 6.99%

動物疫苗市場正成為獸醫公共衛生、食品安全和「同一健康」政策的核心支柱。疫苗接種有助於降低牲畜、家禽、水產養殖動物和伴侶動物的發病率和死亡率，同時也能減少對抗生素的依賴，並支持更安全的動物及動物性產品運輸。

蛋白質消費量的成長、畜牧業生產的集約化、寵物飼養的普及以及跨境和通用感染疾病風險的持續存在，進一步推動了需求。美國疾病管制與預防中心（CDC）等公共衛生機構指出，已知的人類感染疾病中，十分之六可由動物傳播；世界動物衛生組織（WOAH）則強調，動物疾病正對全球生產系統造成重大損失。鑑於這些現實情況，動物疫苗的研發、低溫運輸配送和疾病監測已成為獸醫、生產者、監管機構和動物衛生相關人員的策略重點。

動物疫苗領域的變革性變化

動物疫苗接種的格局正從被動的疾病控制轉向預防性的、數據主導的健康管理。生產者和獸醫越來越重視那些能夠保護牲畜和家禽生產力、降低疫情成本、維護動物福利並提高貿易、殘留和生物安全標準合規性的疫苗接種計劃。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善病原體檢測、抗原優先排序和疫苗接種策略的製定，正在為整個動物疫苗生態系統創造累積價值。 AI 驅動的生物資訊學可以篩檢基因組和蛋白質組數據以識別候選抗原，輔助表位定位，評估致病性標記，並幫助研究人員比較流行株和疫苗株。

關鍵區域洞察

亞太地區因其龐大的畜禽存欄量、不斷擴張的水產養殖業以及對影響肉類動物疾病（包括禽流感、口蹄疫、豬病和水生動物病原體）的持續關注，而被列為重點市場。中國、印度、日本、韓國和澳洲國內需求強勁，但各國的監管和生產條件也存在差異。因此，進入這些市場需要具備針對特定區域的疫苗組合、一致的診斷方法和分銷能力。

主要群體洞察

東協地區的需求主要受高密度家禽和生豬養殖、水產養殖業發展以及為保護蛋白質供應免受地方性疾病和新興疾病侵害而需要大規模疫苗接種的驅動。海灣合作理事會（GCC）市場正日趨專業化，對伴侶動物照護、馬匹健康、駱駝健康和食品安全的投資正在影響乾旱炎熱環境下的採購、進口法規和分銷策略。

主要國家的概況

美國和加拿大在伴侶動物醫學、商業牲畜疫苗接種、完善的診斷網路和成熟的獸醫服務模式方面處於領先地位。同時，墨西哥和巴西則優先發展疫苗，以保護牛、家禽、豬以及出口導向生產。巴西龐大的動物性蛋白質生產規模使其在區域疾病預防中具有戰略意義，而墨西哥與北美畜禽貿易的緊密聯繫進一步凸顯了可靠的疫苗接種和生物安全計畫的重要性。

為行業領導者提供的實用建議

行業領導者應根據​​已證實的疾病負擔、物種特異性經濟效益、區域生物安全挑戰以及不斷發展的「同一健康」優先事項，優先考慮其疫苗組合。投資應集中於能夠實現更快病毒株更新、更高熱穩定性、更穩定生產和更便捷給藥的平台，尤其適用於家禽、豬、牛、水產養殖和伴侶動物。

調查方法

本執行摘要基於權威公共資訊來源的二手研究，包括獸醫公共衛生機構、監管機構、行業協會、同行評審文獻和經認可的動物衛生組織。引用的資訊來源包括世界衛生組織 (WHO)、世界動物衛生組織 (WOAH)、聯合國糧農組織 (FAO)、美國疾病管制與預防中心 (CDC)、美國農業部 (USDA)、歐洲藥品管理局 (EMA)、各國獸醫主管部門以及公開的科學與政策文件。

結論

獸用疫苗正從單純的輔助獸藥類別轉變為保障食品安全、公共衛生、動物福利和永續畜牧業發展的策略工具。該市場的長期重要性源於疾病預防、合理使用抗菌藥物、伴侶動物「人性化」、跨境疾病控制以及疫苗平台創新等方面的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 動物疫苗市場：依產品分類

  • 去活化疫苗
  • 減毒活疫苗
  • 藥效疫苗
  • 重組疫苗
  • 次單位疫苗

第8章：動物疫苗市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 家禽
    • 羊
    • 豬

第9章 動物疫苗市場：依疾病類型分類

  • 細菌感染疾病
    • 梭狀芽孢桿菌
    • 大腸桿菌
    • 鉤端螺旋體病
    • 巴斯德氏菌
  • 黴菌感染疾病
  • 寄生蟲感染疾病
    • 體外寄生蟲
    • 體內寄生蟲
  • 病毒感染疾病
    • 禽流感病毒
    • 牛病毒性腹瀉病毒（BVDV）
    • 口蹄疫病毒（FMDV）
    • 新城疫病毒
    • 豬繁殖與呼吸綜合症病毒（PRRSV）
    • 狂犬病毒

第10章：動物疫苗市場：依給藥途徑分類

  • 注射疫苗
    • 肌肉內注射（IM）
    • 靜脈注射（IV）
    • 皮下（SC）
  • 口服疫苗

第11章 動物疫苗市場：依通路分類

  • 網路藥房
  • 零售藥房
  • 動物診所

第12章 動物疫苗市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 動物疫苗市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 動物疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Biogenesis Bago SA
  • BioVaxys Technology Corporation
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health
  • Elanco Animal Health Inc.
  • Endovac Animal Health, LLC by Immvac Inc.
  • Hester Biosciences Limited
  • HIPRA, SA
  • Indian Immunologicals Limited
  • Kemin Industries, Inc.
  • Merck KGaA
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • SAN Vet Holding GmbH
  • Sanofi SA
  • Seppic SA
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics, LLC
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.
Product Code: MRR-ED54C46E8F03

The Animal Vaccines Market is projected to grow by USD 23.40 billion at a CAGR of 6.99% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.58 billion
Estimated Year [2026] USD 15.53 billion
Forecast Year [2032] USD 23.40 billion
CAGR (%) 6.99%

The animal vaccines market is becoming a core pillar of veterinary public health, food security, and One Health policy. Vaccination helps reduce morbidity and mortality in livestock, poultry, aquaculture, and companion animals while lowering reliance on antimicrobials and supporting safer movement of animals and animal-derived products.

Demand is being reinforced by rising protein consumption, intensification of livestock production, expansion of pet ownership, and persistent risk from transboundary and zoonotic diseases. Verified public-health agencies such as the CDC note that six in ten known infectious diseases in people can spread from animals, while WOAH emphasizes that animal diseases cause substantial losses to global production systems. These realities keep animal vaccine development, cold-chain distribution, and disease surveillance high on the strategic agenda for veterinarians, producers, regulators, and animal health stakeholders.

Transformative Shifts in the Animal Vaccine Landscape

The animal vaccine landscape is shifting from reactive disease control toward preventive, data-led health management. Producers and veterinarians increasingly prioritize vaccination programs that protect herd and flock productivity, limit outbreak costs, support animal welfare, and improve compliance with trade, residue, and biosecurity standards.

Technology is also reshaping the competitive environment. Conventional inactivated and live attenuated vaccines remain widely used, but recombinant, vector-based, subunit, DNA, and mRNA platforms are gaining attention because they can improve antigen targeting, support differentiated immune responses, and accelerate development cycles. At the same time, regulators are placing stronger emphasis on pharmacovigilance, quality assurance, manufacturing consistency, and demonstrated field effectiveness, raising the bar for manufacturers across the animal health value chain.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the animal vaccines ecosystem by improving how pathogens are detected, antigens are prioritized, and vaccination strategies are deployed. AI-enabled bioinformatics can screen genomic and proteomic data to identify candidate antigens, support epitope mapping, assess virulence markers, and help researchers compare circulating strains with vaccine strains.

Beyond discovery, AI supports outbreak forecasting, cold-chain monitoring, manufacturing quality analytics, pharmacovigilance, and adverse-event signal detection. When integrated with veterinary diagnostics, farm management systems, geospatial data, and epidemiological databases, AI can help companies and public agencies move from calendar-based vaccination to more risk-based immunization planning. The practical impact is faster response, better targeting, stronger compliance, and improved resilience against diseases that threaten animal health and food supply.

Key Regional Insights

Asia-Pacific is a high-priority region due to its large livestock and poultry populations, expanding aquaculture sector, and continued focus on diseases affecting food animals, including avian influenza, foot-and-mouth disease, porcine diseases, and aquatic animal pathogens. China, India, Japan, South Korea, and Australia combine strong domestic demand with different regulatory and production profiles, making localized vaccine portfolios, diagnostic alignment, and distribution capability essential for market access.

North America benefits from advanced veterinary infrastructure, strong companion animal care, established livestock biosecurity programs, and broad use of diagnostics to guide preventive health planning. Europe is shaped by rigorous regulatory oversight, farm-to-fork safety priorities, antimicrobial stewardship, animal welfare standards, and high adoption of preventive veterinary medicine. Latin America, led by Brazil and Mexico, remains important for cattle, poultry, swine, and export-oriented animal protein systems, where vaccination supports productivity, trade continuity, and control of regionally significant infectious diseases.

The Middle East and Africa show rising need for vaccines that address climate-sensitive disease spread, cross-border animal movement, emerging companion animal care, and food security priorities. In these regions, affordability, heat-stable formulations, public procurement, surveillance-linked vaccination campaigns, and last-mile veterinary access are decisive factors for effective immunization coverage and sustainable disease prevention.

Key Group Insights

ASEAN demand is supported by dense poultry and swine production, aquaculture growth, and the need for scalable vaccination to protect protein supply against endemic and emerging diseases. The GCC market is more specialized, with companion animal care, equine health, camel health, and food-security investments influencing procurement, import controls, and distribution strategies across arid and high-temperature environments.

The European Union remains a benchmark for regulatory quality, traceability, antimicrobial-reduction policy, and animal welfare requirements, creating opportunities for vaccines that demonstrate safety, efficacy, consistency, and measurable value in field conditions. BRICS countries represent a broad strategic base because they combine large animal populations, expanding domestic manufacturing capabilities, public-sector disease-control priorities, and increasing emphasis on self-reliant animal health systems.

G7 markets are important for innovation, premium veterinary care, advanced companion animal medicine, and high compliance standards, while NATO countries overlap with many advanced veterinary, food-security, and biosecurity systems. Across these groups, successful companies align product registration, field evidence, pharmacovigilance, supply reliability, and local technical support with disease burdens, species economics, and policy objectives.

Key Country Insights

The United States and Canada are driven by advanced companion animal medicine, commercial livestock vaccination, strong diagnostic networks, and mature veterinary service models, while Mexico and Brazil emphasize vaccines that protect cattle, poultry, swine, and export-oriented production. Brazil's scale in animal protein gives it strategic importance for regional disease prevention, and Mexico's integration with North American livestock and poultry trade reinforces the value of reliable vaccination and biosecurity programs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine high veterinary standards with strong attention to antimicrobial stewardship, animal welfare, traceability, and preventive herd health. Russia's market reflects large-scale livestock needs, transboundary disease preparedness, and domestic production priorities, making vaccine availability and local adaptation central to animal health planning.

China and India are central to global demand because of their large animal populations, protein consumption, poultry and dairy systems, and government-led disease-control programs. Japan, Australia, and South Korea add high-value opportunities through strict biosecurity, advanced veterinary services, strong disease surveillance, and premium livestock and companion animal segments where quality, safety, and regulatory compliance are essential.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize vaccine portfolios around verified disease burden, species economics, regional biosecurity gaps, and evolving One Health priorities. Investment should focus on platforms that enable faster strain updates, stronger thermostability, consistent manufacturing, and easier administration, especially for poultry, swine, cattle, aquaculture, and companion animals.

Companies should expand partnerships with diagnostic laboratories, veterinary networks, universities, producer groups, and public agencies to link vaccination with surveillance, field evidence, and outbreak preparedness. Digital traceability, AI-supported demand planning, cold-chain visibility, and post-vaccination monitoring can improve service levels and reduce waste. Leaders should also build regulatory agility by generating robust safety, efficacy, quality, and pharmacovigilance data suitable for multiple jurisdictions.

Research Methodology

This executive summary is built on secondary research from authoritative public sources, including veterinary public-health agencies, regulatory bodies, trade organizations, peer-reviewed literature, and recognized animal health institutions. Sources considered include WHO, WOAH, FAO, CDC, USDA, EMA, national veterinary authorities, and publicly available scientific and policy documents.

The analysis applies a triangulated methodology that compares disease epidemiology, species-level demand drivers, vaccination policy, regulatory trends, technology adoption, and regional market conditions. Qualitative insights are validated against observable factors such as livestock production systems, companion animal care trends, outbreak preparedness, antimicrobial stewardship initiatives, animal welfare policy, and animal health innovation activity.

Conclusion

Animal vaccines are moving from a supporting veterinary product category to a strategic tool for food security, public health, animal welfare, and sustainable animal production. The market's long-term relevance is supported by disease prevention needs, antimicrobial stewardship, companion animal humanization, cross-border disease preparedness, and innovation in vaccine platforms.

Companies that combine scientific credibility, region-specific portfolios, reliable manufacturing, regulatory discipline, and digital intelligence will be best positioned to compete. As One Health priorities intensify, animal vaccination will remain essential for reducing disease risk, protecting animal welfare, and strengthening resilient global protein supply chains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Vaccines Market, by Product

  • 7.1. Inactivated Vaccines
  • 7.2. Live Attenuated Vaccines
  • 7.3. mRNA Vaccines
  • 7.4. Recombinant Vaccines
  • 7.5. Subunit Vaccines

8. Animal Vaccines Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock Animals
    • 8.2.1. Cattle
    • 8.2.2. Poultry
    • 8.2.3. Sheep
    • 8.2.4. Swine

9. Animal Vaccines Market, by Disease Type

  • 9.1. Bacterial Infections
    • 9.1.1. Clostridial
    • 9.1.2. E. Coli
    • 9.1.3. Leptospirosis
    • 9.1.4. Pasteurella
  • 9.2. Fungal Infections
  • 9.3. Parasitic Infections
    • 9.3.1. Ectoparasites
    • 9.3.2. Endoparasites
  • 9.4. Viral Infections
    • 9.4.1. Avian Influenza Virus
    • 9.4.2. Bovine Viral Diarrhea Virus (BVDV)
    • 9.4.3. Foot-and-Mouth Disease Virus (FMDV)
    • 9.4.4. Newcastle Disease Virus
    • 9.4.5. Porcine Reproductive & Respiratory Syndrome Virus (PRRSV)
    • 9.4.6. Rabies Virus

10. Animal Vaccines Market, by Route of Administration

  • 10.1. Injectable Vaccines
    • 10.1.1. Intramuscular (IM)
    • 10.1.2. Intravenous (IV)
    • 10.1.3. Subcutaneous (SC)
  • 10.2. Oral Vaccines

11. Animal Vaccines Market, by Distribution Channel

  • 11.1. Online Pharmacies
  • 11.2. Retail Pharmacies
  • 11.3. Veterinary Clinics

12. Animal Vaccines Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Animal Vaccines Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Vaccines Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Biogenesis Bago S.A.
  • 16.2. BioVaxys Technology Corporation
  • 16.3. Boehringer Ingelheim International GmbH
  • 16.4. Brilliant Bio Pharma Private limited
  • 16.5. Ceva Sante Animale
  • 16.6. China Animal Husbandry Industry Co., Ltd.
  • 16.7. Dalan Animal Health
  • 16.8. Elanco Animal Health Inc.
  • 16.9. Endovac Animal Health, LLC by Immvac Inc.
  • 16.10. Hester Biosciences Limited
  • 16.11. HIPRA, S.A.
  • 16.12. Indian Immunologicals Limited
  • 16.13. Kemin Industries, Inc.
  • 16.14. Merck KGaA
  • 16.15. Neogen Corporation
  • 16.16. Phibro Animal Health Corporation
  • 16.17. SAN Vet Holding GmbH
  • 16.18. Sanofi S.A.
  • 16.19. Seppic S.A.
  • 16.20. Torigen Pharmaceuticals Inc.
  • 16.21. Vaxxinova GmbH
  • 16.22. VEROVACCiNES GmbH
  • 16.23. Vetigenics, LLC
  • 16.24. Vetoquinol SA
  • 16.25. Virbac, Inc.
  • 16.26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL VACCINES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL VACCINES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL VACCINES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CLOSTRIDIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CLOSTRIDIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CLOSTRIDIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL E. COLI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL E. COLI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL E. COLI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PASTEURELLA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PASTEURELLA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PASTEURELLA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ECTOPARASITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ECTOPARASITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ECTOPARASITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOPARASITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOPARASITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOPARASITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RABIES VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RABIES VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RABIES VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ORAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ORAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ORAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. G7 ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. NATO ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 347. FRANCE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 348. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 349. RUSSIA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. RUSSIA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 356. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 357. RUSSIA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
  • TABLE 358. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 359. RUSSIA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
  • TABLE 360. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 361. ITALY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 362. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 363. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. ITALY ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 365. ITALY ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 366. ITALY ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 367. ITALY ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 20